A panel of hypermethylated genes (BMP3, RASSF1A, BNC1, MESTv2, TFPI2, APC, SFRP1 and SFRP2) are able to differentiate between patients with pancreatic adenocarcinoma and a most relevant control group. Here, SFRP1 is linked to pancreatic adenocarcinoma.